ArticleNeuroradiology2026
Consensus on the use of artificial intelligence in the management and measurement of vestibular schwannomas: A protocol for a modified delphi consensus.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionThe assessment of vestibular schwannomas (VS) requires a standardized approach as growth is a key element in defining treatment strategy. Volumetric measurements offer higher sensitivity and precision, but existing methods of image segmentation, are labour-intensive and prone to variability. Artificial intelligence (AI) frameworks to segment VS using magnetic resonance imaging (MRI) achieving state-of-the-art capability can fully automate the detection and segmentation of VS. These tools can be used for automating the extraction process of various linear and volumetric measurements. A consistent approach to recording data, facilitated by AI, will allow the accumulation and comparison of evidence to identify the most effective treatments for patients with VS.
aimsThis protocol aims to develop a Delphi consensus for the assessment of VS and deployment of AI-based image analysis as a tool for use in VS management.
methodsA three-phase consensus study will be undertaken; Phase 1: systematic review (PROSPERO registration number CRD42024604452) of trials and observational studies reporting the measurement of VS to identify a list of candidate indicators; Phase 2: refinement of this list and development of a set of questionnaire questions performed by our local steering committee; and Phase 3: a two-round Delphi questionnaire and consensus meeting with expert stakeholders from the British Skull Base Society (BSBS), European Skull Base Society (ESBS) and European Society of Head and Neck Radiology (ESHNR). ETHICS AND DISSEMINATION: Participants will be recruited through professional bodies. The core reporting set will be disseminated through peer-reviewed publication, co-production with journal editors, research funders and professional bodies, and presentation at national conferences. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.